ADDISON, Texas, Sept. 4 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it is scheduled to present at the Thomas Weisel Partners Healthcare Conference at 3:15 p.m. Eastern Time on Thursday, September 4, 2008.
About ULURU Inc.:
ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.
This press release contains certain statements that are forward-looking
within the meaning of Section 27a of the Securities Act of 1933, as
amended, including but not limited to statements made relating to the
response to the product from physicians and nurses, the importance of use
of the product for burn victims, our expectation of enhanced patient
comfort, the ability to use the product for chronic wounds, the perception
of the product as a transformational innovation in the wound care market,
our plan to add two products to our wound care franchise in 2009, and our
expectation of filing a 510k in the third quarter and a product launch in
the first quarter of 2009. These statements are subject to numerous risks
and uncertainties, including but not limited to the risk factors detailed
in the Company's Annual Report on Form 10-KSB for the year ended December
31, 2007, Quarterly Report on Form 10-Q for the quarter ended March 31,
2008 and other reports filed by us with the Securities and Exchange
Kerry P. Gray
President & CEO
Terry K. Wallberg
Vice President & CFO
|SOURCE ULURU Inc.|
Copyright©2008 PR Newswire.
All rights reserved